Rishika Chugh (@rishikachughmd) 's Twitter Profile
Rishika Chugh

@rishikachughmd

Gastroenterologist with focus on inflammatory bowel disease & Director of Intestinal Ultrasound @UCSF II Alum @UCSF, @Yale, @montefioreNYC

ID: 1923434719

calendar_today01-10-2013 13:04:07

327 Tweet

881 Followers

330 Following

Joshua M. Steinberg, MD (@joshsteinbergmd) 's Twitter Profile Photo

💡A shift in practice — rotavirus vaccine may be given to infants exposed to anti-TNF in utero. 💉 Live vaccines can be given to infants whose mothers are breastfeeding on biologics. 👏🏻 PIANO group for compiling these data + forming these expert consensus recs. #DDW2024

💡A shift in practice — rotavirus vaccine may be given to infants exposed to anti-TNF in utero. 
💉 Live vaccines can be given to infants whose mothers are breastfeeding on biologics. 
👏🏻 <a href="/PIANOIBD/">PIANO</a> group for compiling these data + forming these expert consensus recs. #DDW2024
Rishika Chugh (@rishikachughmd) 's Twitter Profile Photo

A tremendous effort from Uma Mahadevan and Millie Long consolidating pregnancy data from around the 🌎 -rotavirus💉should be given on schedule in infants with in utero TNF -active flare=teratogen -breastfeeding safe with mAb use -preeclampsia is a major risk, start low dose asa

A tremendous effort from <a href="/UmaMahadevanIBD/">Uma Mahadevan</a> and <a href="/MLongMD/">Millie Long</a> consolidating pregnancy data from around the 🌎
-rotavirus💉should be given on schedule in infants with in utero TNF
-active flare=teratogen
-breastfeeding safe with mAb use
-preeclampsia is a major risk, start low dose asa
Uma Mahadevan (@umamahadevanibd) 's Twitter Profile Photo

✅Wound healing after delivery among IBD pts delayed by immunomodulator use (episiotomy) but not anti-TNF use ✅44% rate of c section, half elective. Room for improvement ✅great presentation by ⁦Sara Lewin, MD⁩ ⁦PIANO⁩ ⁦Digestive Disease Week

✅Wound healing after delivery among IBD pts delayed by immunomodulator use (episiotomy) but not anti-TNF use
✅44% rate of c section, half elective. Room for improvement
✅great presentation by ⁦<a href="/SaraLewinMD/">Sara Lewin, MD</a>⁩
⁦<a href="/PIANOIBD/">PIANO</a>⁩ ⁦<a href="/DDWMeeting/">Digestive Disease Week</a>⁩
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

🍇#GIReconnect24 Gi Health Foundation 📡 #IUS accelerates & simplify #IBD care Rishika Chugh ⏰No time wasted waiting for CT/MR or colonoscopy to be scheduled & on cumbersome logistics 📸Crash course on IUS parameters & indications & future utility 👇🏽

🍇#GIReconnect24 <a href="/GiHFoundation/">Gi Health Foundation</a> 

📡 #IUS accelerates &amp; simplify #IBD care <a href="/RishikaChughMD/">Rishika Chugh</a>

⏰No time wasted waiting for CT/MR or colonoscopy to be scheduled &amp; on cumbersome logistics

📸Crash course on IUS parameters &amp; indications &amp; future utility 👇🏽
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

⭐️Panel discussion #GIReconnect24 Maria T. Abreu: How do you define #IBD severity to pts? ✅Current symptoms & endo findings ✅Longitudinal assessment: prior Rx/response, time to LOR, 🏥✂️steroids use & response ✅Dis burden on QOL & daily living (urgency, depression, disability..)

⭐️Panel discussion #GIReconnect24 <a href="/ibddocmaria/">Maria T. Abreu</a>: How do you define #IBD severity to pts?
✅Current symptoms &amp; endo findings
✅Longitudinal assessment: prior Rx/response, time to LOR, 🏥✂️steroids use &amp; response
✅Dis burden on QOL &amp; daily living (urgency, depression, disability..)
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

🍇#GIReconnect24 Sara Horst MD, MPH, FACG stresses the importance of Early Effective therapy after #Crohns dx 💎#PROFILE Early IFX+IMM ✅80 % steroid-free remission at week48 ✅70% Endo remission wk48 ! #EarlyTherapyDoesIt 🚫Stop wasting time w ineffective 5ASA, steroids courses etc..

🍇#GIReconnect24 <a href="/HorstIBDDoc/">Sara Horst MD, MPH, FACG</a> stresses the importance of Early Effective therapy after #Crohns dx 

💎#PROFILE Early IFX+IMM
✅80 % steroid-free remission at week48
✅70% Endo remission wk48 !

#EarlyTherapyDoesIt
🚫Stop wasting time w ineffective 5ASA, steroids courses etc..
Aline Charabaty, MD, FACG, AGAF (@dcharabaty) 's Twitter Profile Photo

🍇#GIReconnect24 Gi Health Foundation breaking the therapeutic glass ceiling Maria T. Abreu ✅Early Dx & prognostication ✅Effective Rx early ✅Combo Rx: TNFi or JAKi + IL12/23 or IL23 or Vedo + “ a side of #microbiota therapy (Choice per 🎯: Treat severe/refractory dis; treat IBD+EIM)

🍇#GIReconnect24 <a href="/GiHFoundation/">Gi Health Foundation</a> breaking the therapeutic glass ceiling <a href="/ibddocmaria/">Maria T. Abreu</a> 

✅Early Dx &amp; prognostication
✅Effective Rx early
✅Combo Rx: TNFi or JAKi + IL12/23 or IL23 or Vedo + “ a side of #microbiota therapy
(Choice per 🎯: Treat severe/refractory dis; treat IBD+EIM)
Uma Mahadevan (@umamahadevanibd) 's Twitter Profile Photo

Hot of the press: Upadacitinib safety in pregnancy. 128 maternal pregnacies all exposed in the first trimester primarily. MotherToBaby Mette Julsgaard Millie Long link.springer.com/article/10.100…

Rishika Chugh (@rishikachughmd) 's Twitter Profile Photo

Sharing our case report on the use of IUS in a patient with microscopic colitis - from initial diagnosis to treatment response. IUS may be a useful tool for monitoring response to treatment in patients with microscopic colitis. InternationalBowelUS academic.oup.com/ibdjournal/adv…

Rishika Chugh (@rishikachughmd) 's Twitter Profile Photo

It was such a pleasure to have Sanket Patel this past week UCSFIBD for InternationalBowelUS module 2 training! He is changing the way IBD is practiced Virtua Health, and there is now an IUS option available in the Philadelphia/ NJ area!

It was such a pleasure to have <a href="/DrSanket_Patel/">Sanket Patel</a> this past week <a href="/ucsfibd/">UCSFIBD</a> for <a href="/BowelUltrasound/">InternationalBowelUS</a> module 2 training! He is changing the way IBD is practiced <a href="/VirtuaHealth/">Virtua Health</a>, and there is now an IUS option available in the Philadelphia/ NJ area!